GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » Float Percentage Of Total Shares Outstanding

Repligen (FRA:RGN) Float Percentage Of Total Shares Outstanding : 85.48% (As of Jun. 03, 2024)


View and export this data going back to . Start your Free Trial

What is Repligen Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Repligen's float shares is 47.77 Mil. Repligen's total shares outstanding is 55.88 Mil. Repligen's float percentage of total shares outstanding is 85.48%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Repligen's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Repligen's Institutional Ownership is 85.89%.

Repligen Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Repligen's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=47.77/55.88
=85.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Repligen (FRA:RGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TFX ATR XRAY STVN MMSI HAE NVST AZTA ICUI WRBY ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN
Traded in Other Exchanges
RGEN:USA RGN:Germany
Address
41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453
Website
https://www.repligen.com
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Repligen (FRA:RGN) Headlines

No Headlines